Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma

Table 1 Baseline characteristics of the patients, n (%)

Characteristics	N = 142
Age, median (IQR) (years)	62 (35-80)
Sex
Male	114 (80.3)
Female	28 (19.7)
ECOG
0	92 (64.8)
1	50 (35.2)
≥2	0 (0)
Premedication
Dexamethasone	107 (75.4)
Antihistamine	35 (24.6)
cTNM stage
I	1 (0.7)
II	33 (23.2)
III	86 (60.6)
IV	22 (15.5)
cT stage
T1	0 (0)
T2	36 (25.4)
T3	96 (67.6)
T4	10 (7.0)
cN stage
N0	20 (14.1)
N1	54 (38.0)
N2	51 (35.9)
N3	17 (12.0)

The clinical stage was assessed using endoscopy or computed tomography and was classified according to the Union for International Cancer Control tumor–node–metastasis classification, 8^th edition. IQR: Interquartile range; cTNM stage: Clinical stage; TNM: Tumor–node–metastasis; ECOG: Eastern Cooperative Oncology Group.